+ +

•  

   

     Western blot analysis of GABA A Receptor beta 1 expression in Human cerebellum lysate.    

  
  

The GABA_A receptor beta1 antibody is a specialized tool used to detect the beta1 subunit of gamma-aminobutyric acid type A (GABA_A) receptors, which are ligand-gated chloride channels mediating fast inhibitory neurotransmission in the central nervous system. GABA_A receptors are heteropentamers composed of various subunit combinations (e.g., α, β, γ, δ), with the beta1 subunit (encoded by *GABRB1*) playing a critical role in receptor assembly, synaptic clustering, and pharmacological modulation. This subunit is expressed in specific brain regions, including the hippocampus, cerebellum, and cortex, influencing neuronal excitability and network stability.

Antibodies targeting the beta1 subunit enable researchers to study receptor localization, expression levels, and alterations in neurological or psychiatric disorders, such as epilepsy, anxiety, and sleep disturbances. They are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to explore GABA_A receptor diversity and function. Dysregulation of beta1-containing receptors has been linked to pathophysiological mechanisms, making this antibody valuable for investigating GABAergic signaling deficits and drug interactions (e.g., benzodiazepines, anesthetics). Validation of specificity is essential, as cross-reactivity with other beta subunits (beta2/beta3) may occur. Overall, the beta1 antibody serves as a key reagent in neuroscience research, bridging molecular studies with therapeutic development for GABA-related disorders.